Search results
Results From The WOW.Com Content Network
GSK plc (an acronym from its former name GlaxoSmithKline plc) is a British multinational pharmaceutical and biotechnology company with global headquarters in London. It was established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham, which was itself a merger of a number of pharmaceutical companies around the Smith, Kline & French firm.
In 1919 Henry Wellcome bought a 105-acre site in Beckenham, Kent, which cost £32,000. The site had belonged to the Langley family since 1350. Langley Court had been built in 1886 by James Bucknall, who lived in the house with his family until 1914. It was named the Wellcome Research Laboratories [1] in 1946 after the Wellcome Chemical Research ...
Early life and career. Girolami was born in Italy on 25 January 1926. [1] He attended the London School of Economics . Girolami joined Glaxo in 1965 as a Financial Controller. He became finance director in 1968 when aged 42. In April 1980 it was announced that he would become chief executive.
GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. [4] [5] The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology ...
For premium support please call: 800-290-4726 more ways to reach us
This page was last edited on 4 June 2022, at 00:33 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply ...
c. 1,100 (2023) Website. viivhealthcare .com. ViiV Healthcare ( / ˈviːv / VEEV) is a British multinational pharmaceutical company specializing in the research and development of medicines to treat and prevent HIV/AIDS, with its global headquarters in London. The company was created as a joint venture by GSK and Pfizer in November 2009, with ...
Business executive. Judith Carol Lewent is a business executive who served as chief financial officer of Merck & Co. from 1990 until her retirement from the company in 2007. [1] Since her retirement from Merck, she has continued to serve on multiple corporate boards, including the boards of GlaxoSmithKline, Thermo Fisher Scientific and Motorola ...